These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. Matthaiou DK; Panos G; Adamidi ES; Falagas ME PLoS Negl Trop Dis; 2008 Mar; 2(3):e194. PubMed ID: 18335068 [TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy of cysticercosis. Review about its pharmacokinetics and toxicology]. Herrera LA; Benítez-Bribiesca L; Sotelo J; Ostrosky-Wegman P Gac Med Mex; 2000; 136(5):477-89. PubMed ID: 11080931 [TBL] [Abstract][Full Text] [Related]
6. Anthelmintics for people with neurocysticercosis. Monk EJM; Abba K; Ranganathan LN Cochrane Database Syst Rev; 2021 Jun; 6(6):CD000215. PubMed ID: 34060667 [TBL] [Abstract][Full Text] [Related]
7. Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution. Garcia HH; Del Brutto OH; Epilepsy Behav; 2017 Nov; 76():158-162. PubMed ID: 28606690 [TBL] [Abstract][Full Text] [Related]
8. Neurocysticercosis: Diagnostic problems & current therapeutic strategies. Rajshekhar V Indian J Med Res; 2016 Sep; 144(3):319-326. PubMed ID: 28139530 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Garcia HH; Gonzales I; Lescano AG; Bustos JA; Zimic M; Escalante D; Saavedra H; Gavidia M; Rodriguez L; Najar E; Umeres H; Pretell EJ; Lancet Infect Dis; 2014 Aug; 14(8):687-695. PubMed ID: 24999157 [TBL] [Abstract][Full Text] [Related]
10. A case of imported neurocysticercosis in Portugal. Valadas E; Badura R; Marques T; Neno M; Boura M; Sutre AF; Beato S; Grácio MA; Neves JC J Infect Dev Ctries; 2015 Jan; 9(1):114-7. PubMed ID: 25596581 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of neurocysticercosis: a review]. Nogales-Gaete J; Arriagada C; Salinas R Rev Med Chil; 2006 Jun; 134(6):789-96. PubMed ID: 17130956 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of medical treatment of neurocysticercosis: a study of 65 cases in Cheju Island, Korea. Kim SK; Wang KC; Paek SH; Hong KS; Cho BK Surg Neurol; 1999 Dec; 52(6):563-9. PubMed ID: 10660021 [TBL] [Abstract][Full Text] [Related]
14. Neurocysticercosis: a review of current status and management. Sinha S; Sharma BS J Clin Neurosci; 2009 Jul; 16(7):867-76. PubMed ID: 19394828 [TBL] [Abstract][Full Text] [Related]
15. Neurocysticercosis: A case study of a Mongolian traveler who visited China and India with an updated review in Asia. Davaasuren A; Davaajav A; Ukhnaa B; Purvee A; Unurkhaan S; Luvsan A; Logan JE; Ito A Travel Med Infect Dis; 2017; 20():31-36. PubMed ID: 28478337 [TBL] [Abstract][Full Text] [Related]
16. [Neurocysticercosis: up-dating in diagnosis and treatment]. Del Brutto OH Neurologia; 2005 Oct; 20(8):412-8. PubMed ID: 16217690 [TBL] [Abstract][Full Text] [Related]
17. Current approaches to cysticidal drug therapy for neurocysticercosis. Del Brutto OH Expert Rev Anti Infect Ther; 2020 Aug; 18(8):789-798. PubMed ID: 32331507 [TBL] [Abstract][Full Text] [Related]
18. [Clinical Analysis of 94 Patients with Neurocysticercosis in Sichuan Province]. Liu Y; Hu TY; Zhong CJ; Lv XJ Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2016 Apr; 34(2):118-22. PubMed ID: 30124241 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis. Jung-Cook H Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156 [TBL] [Abstract][Full Text] [Related]